{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:43:11Z","timestamp":1793191391817,"version":"4.5.0"},"reference-count":356,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T00:00:00Z","timestamp":1470355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III\u2019","doi-asserted-by":"crossref","award":["PI06\/0024"],"award-info":[{"award-number":["PI06\/0024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III\u2019","doi-asserted-by":"crossref","award":["PS09\/00748"],"award-info":[{"award-number":["PS09\/00748"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III\u2019","doi-asserted-by":"crossref","award":["PI12\/00060"],"award-info":[{"award-number":["PI12\/00060"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III\u2019","doi-asserted-by":"crossref","award":["PI15\/00525"],"award-info":[{"award-number":["PI15\/00525"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III\u2019","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European IMI BTCure Program"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.autrev.2016.07.026","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T23:12:41Z","timestamp":1470179561000},"page":"1013-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers"],"prefix":"10.1016","volume":"15","author":[{"given":"Raquel","family":"L\u00f3pez-Mej\u00edas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Ferraz-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Genre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Remuzgo-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rodriguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.07.026_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0010","first-page":"36","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis","volume":"30","author":"Wolfe","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0015","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00002281-200203000-00007","article-title":"Coronary artery disease and rheumatoid arthritis","volume":"14","author":"Goodson","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0025","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow-up study of a primary care-based inception cohort","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0030","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semarthrit.2005.03.004","article-title":"Rheumatoid arthritis: a disease associated with accelerated atherogenesis","volume":"35","author":"Gonzalez-Gay","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0045","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2006.059980","article-title":"Do cardiovascular risk factors confer the same risk for cardiovascular outcome in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?","volume":"67","author":"Gonzalez","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2008.095596","article-title":"Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis","volume":"68","author":"Stavropoulos-Kalinoglou","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1196\/annals.1422.038","article-title":"Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors","volume":"1108","author":"Gerli","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2016.07.026_bb0065","first-page":"435","article-title":"Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis","volume":"32","author":"Dessein","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0070","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/art.21288","article-title":"Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors","volume":"52","author":"Chung","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0075","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/heartjnl-2015-307838","article-title":"Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders","volume":"102","author":"Agca","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.autrev.2016.07.026_bb0080","first-page":"943","article-title":"Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis","volume":"34","author":"Dessein","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0085","first-page":"115","article-title":"Inflammation and endothelial dysfunction in rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0090","first-page":"1219","article-title":"High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/ard.2010.145482","article-title":"Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment","volume":"70","author":"Crowson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0105","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/annrheumdis-2011-201209","article-title":"Carotid ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis: when and for whom?","volume":"71","author":"Gonz\u00e1lez-Gay","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0110","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semarthrit.2008.01.012","article-title":"Carotid intima\u2013media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis","volume":"38","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.30265","article-title":"Carotid atherosclerosis predicts incident acute coronary syndrome in rheumatoid arthritis","volume":"63","author":"Evans","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2010.10.052","article-title":"TNFA-308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"216","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0125","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2012.06.008","article-title":"NFKB1-94ATTG ins\/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis","volume":"224","author":"L\u00f3pez-Mej\u00edas","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0130","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/ard.2005.046540","article-title":"Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis","volume":"65","author":"Otero","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0135","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2016.03.014","article-title":"Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do","volume":"15","author":"Szekanecz","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb0140","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.autrev.2010.06.001","article-title":"How early is the atherosclerotic risk in rheumatoid arthritis?","volume":"9","author":"Bartoloni","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb0145","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb0150","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb0155","doi-asserted-by":"crossref","first-page":"710928","DOI":"10.1155\/2013\/710928","article-title":"Metabolic syndrome in rheumatoid arthritis","volume":"2013","author":"Ferraz-Amaro","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2016.07.026_bb0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrrheum.2014.121","article-title":"Rheumatoid arthritis and metabolic syndrome","volume":"10","author":"Kerekes","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0165","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.2174\/1381612043382765","article-title":"Endothelial dysfunction: methods of assessment and application to hypertension","volume":"10","author":"Nadar","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2016.07.026_bb0170","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","article-title":"Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis","volume":"340","author":"Celermajer","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0180","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9343(03)00133-5","article-title":"HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis","volume":"114","author":"Gonzalez-Juanatey","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.md.0000101572.76273.60","article-title":"Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease","volume":"82","author":"Gonzalez-Juanatey","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2016.07.026_bb0195","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/annrheumdis-2012-203101","article-title":"Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study","volume":"73","author":"Corrales","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0200","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/annrheumdis-2013-203688","article-title":"Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"72","author":"Corrales","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0205","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.ATV.11.5.1245","article-title":"Ultrasonographically assessed carotid morphology and the risk of coronary heart disease","volume":"11","author":"Salonen","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.autrev.2016.07.026_bb0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.semarthrit.2010.06.006","article-title":"Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis","volume":"40","author":"van Sijl","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0220","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar3382","article-title":"Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease","volume":"13","author":"Gonz\u00e1lez-Juanatey","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semarthrit.2008.02.001","article-title":"Endothelial dysfunction, carotid intima\u2013media thickness, and accelerated atherosclerosis in rheumatoid arthritis","volume":"38","author":"Gonzalez-Gay","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrrheum.2012.16","article-title":"Validated methods for assessment of subclinical atherosclerosis in rheumatology","volume":"8","author":"Kerekes","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0235","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/44853","volume":"401","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2016.07.026_bb0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.23149","article-title":"Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis","volume":"58","author":"Farragher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0245","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/art.22527","article-title":"Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of follow-up from the early rheumatoid arthritis study","volume":"56","author":"Mattey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.autrev.2003.10.006","article-title":"Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles","volume":"3","author":"Gonzalez-Gay","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2008.01.019","article-title":"Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis","volume":"38","author":"Rojas-Villarraga","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0260","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/eji.200424964","article-title":"Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes","volume":"34","author":"LeibundGut-Landmann","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0265","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.RES.0000204725.46332.97","article-title":"Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells","volume":"98","author":"Buttice","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2016.07.026_bb0270","first-page":"51","article-title":"Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis","volume":"30","author":"Garcia-Bermudez","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0275","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb0280","first-page":"1697","article-title":"Tumor necrosis factor-alpha \u22121031 T\/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis","volume":"35","author":"Vallv\u00e9","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0285","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/ard.2007.082594","article-title":"Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis","volume":"67","author":"Panoulas","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106823","article-title":"Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis","volume":"9","author":"Genre","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb0295","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3899\/jrheum.111336","article-title":"Polymorphisms of the genes encoding CD40 and growth differentiation factor 15 and in the 9p21.3 region in patients with rheumatoid arthritis and cardiovascular disease","volume":"39","author":"\u00c4rlestig","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049214","article-title":"Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients","volume":"7","author":"Garc\u00eda-Berm\u00fadez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb0305","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines plays a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.07.026_bb0310","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrcardio.2009.57","article-title":"Role for TNF in atherosclerosis? Lessons from autoimmune disease","volume":"6","author":"McKellar","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0315","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jlb.66.4.562","article-title":"Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease","volume":"66","author":"Abraham","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0320","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0002-9440(10)64981-4","article-title":"Lymphoid tissue homing chemokines are expressed in chronic inflammation","volume":"156","author":"Hjelmstrom","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0325","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10038-006-0411-8","article-title":"Inflammation as a risk factor for myocardial infarction","volume":"51","author":"Tanaka","year":"2006","journal-title":"J Hum Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0330","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1074\/jbc.M111727200","article-title":"Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice","volume":"277","author":"Schreyer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.07.026_bb0335","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2016.07.026_bb0340","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","article-title":"Osteoprotegerin, vascular calcification and atherosclerosis","volume":"204","author":"Van Campenhout","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0345","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb0350","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00223-011-9532-y","article-title":"Influence of polymorphisms in the RANKL\/RANK\/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men","volume":"89","author":"Roshandel","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.autrev.2016.07.026_bb0355","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1210\/jc.2003-032054","article-title":"Osteoprotegerin gene polymorphisms in men with coronary artery disease","volume":"89","author":"Soufi","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2016.07.026_bb0360","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00439-012-1224-9","article-title":"Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients","volume":"132","author":"Biscetti","year":"2013","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0365","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1161\/STROKEAHA.111.619288","article-title":"Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability","volume":"42","author":"Straface","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.autrev.2016.07.026_bb0370","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0338","article-title":"Interleukin 6: from bench to bedside","volume":"2","author":"Nishimoto","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-065X.1992.tb01407.x","article-title":"IL-6 and NF-IL6 in acute-phase response and viral infection","volume":"127","author":"Akira","year":"1992","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb0380","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.atherosclerosis.2008.08.036","article-title":"Association of interleukin-6 (IL-6)-174G\/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking","volume":"204","author":"Panoulas","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0385","first-page":"964","article-title":"Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis","volume":"27","author":"Palomino-Morales","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0390","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.atherosclerosis.2011.07.124","article-title":"Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis","volume":"219","author":"L\u00f3pez-Mej\u00edas","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0395","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The soluble interleukin 6 receptor: mechanisms of production and implications in disease","volume":"15","author":"Jones","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2016.07.026_bb0400","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.4049\/jimmunol.152.10.4958","article-title":"The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site","volume":"152","author":"M\u00fcllberg","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0405","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.regpep.2007.09.031","article-title":"A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)\/gp130 is associated with myocardial infarction in a hypertensive population","volume":"146","author":"Benrick","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.autrev.2016.07.026_bb0410","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1399-0039.2011.01774.x","article-title":"Lack of association of IL6R rs2228145 and IL6ST\/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis","volume":"78","author":"L\u00f3pez-Mej\u00edas","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2016.07.026_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047166","article-title":"Analysis of the interferon gamma (rs2430561, +874T\/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis","volume":"7","author":"Garc\u00eda-Berm\u00fadez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb0420","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0425","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2631","article-title":"The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus","volume":"11","author":"Full","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb0430","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.biocel.2007.11.017","article-title":"Atherosclerosis-underlying inflammatory mechanisms and clinical implications","volume":"40","author":"Patel","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0435","doi-asserted-by":"crossref","first-page":"23382","DOI":"10.1074\/jbc.M101216200","article-title":"Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes","volume":"276","author":"Barnes","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.07.026_bb0440","doi-asserted-by":"crossref","first-page":"17005","DOI":"10.1074\/jbc.M412584200","article-title":"The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling","volume":"280","author":"Schoenemeyer","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.07.026_bb0445","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","article-title":"IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses","volume":"12","author":"Krausgruber","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0450","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","article-title":"High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis","volume":"44","author":"Eyre","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0455","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0460","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1186\/ar4608","article-title":"Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis","volume":"16","author":"Garc\u00eda-Berm\u00fadez","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb0465","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ni.1701","article-title":"Selectivity and therapeutic inhibition of kinases: to be or not to be?","volume":"10","author":"Ghoreschi","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0470","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.ajkd.2008.12.025","article-title":"Association of single-nucleotide polymorphisms in JAK3, STAT4, and STAT6 with new cardiovascular events in incident dialysis patients","volume":"53","author":"Sperati","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0475","doi-asserted-by":"crossref","first-page":"318364","DOI":"10.1155\/2015\/318364","article-title":"Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis","volume":"2015","author":"Garc\u00eda-Berm\u00fadez","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2016.07.026_bb0480","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2016.07.026_bb0485","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2015.02.001","article-title":"IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study","volume":"45","author":"Shen","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0490","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2350-14-109","article-title":"Association of interleukin-33 gene single nucleotide polymorphisms with ischemic stroke in north Chinese population","volume":"14","author":"Guo","year":"2013","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062144","article-title":"Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease","volume":"8","author":"Latiano","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb0500","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/ar4554","article-title":"Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis","volume":"16","author":"Li","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb0505","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng.513","article-title":"Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci","volume":"42","author":"Australo-Anglo-American Spondyloarthritis Consortium (TASC)","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0510","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ajhg.2013.08.009","article-title":"The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population","volume":"93","author":"Tu","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143153","article-title":"Protective Role of the Interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients","volume":"10","author":"L\u00f3pez-Mej\u00edas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb0520","first-page":"E83","article-title":"The transcription factor NF-kappa B and the regulation of vascular cell function","volume":"20","author":"De Martin","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0525","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB","volume":"107","author":"Baldwin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.07.026_bb0530","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2011.06.018","article-title":"The NFKB1 ATTG ins\/del polymorphism and risk of coronary heart disease in three independent populations","volume":"219","author":"Vogel","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0535","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/ddh008","article-title":"Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis","volume":"13","author":"Karban","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0540","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/ar3804","article-title":"Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study","volume":"14","author":"Chen","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb0545","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00041433-200210000-00008","article-title":"The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives","volume":"13","author":"Mallat","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0550","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cytogfr.2006.09.002","article-title":"The role of transforming growth factor-beta in atherosclerosis","volume":"17","author":"Singh","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb0555","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0955-0674(98)80141-5","article-title":"Mads and Smads in TGF beta signaling","volume":"10","author":"Attisano","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0560","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1126\/science.1071809","article-title":"Signal transduction by the TGF-beta superfamily","volume":"296","author":"Attisano","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.autrev.2016.07.026_bb0565","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-beta signalling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2016.07.026_bb0570","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ni1549","article-title":"Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer","volume":"9","author":"Tone","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0575","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.ATV.0000133605.89421.79","article-title":"Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta\/Smad signaling in smooth muscle cells of fibrofatty lesions","volume":"24","author":"Kalinina","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0580","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/gut.2009.199679","article-title":"New IBD genetics: common pathways with other diseases","volume":"60","author":"Lees","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2016.07.026_bb0585","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCGENETICS.110.940858","article-title":"Transforming growth factor-beta signaling pathway in patients with Kawasaki disease","volume":"4","author":"Shimizu","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077695","article-title":"SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients","volume":"8","author":"Garc\u00eda-Berm\u00fadez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb0595","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar3444","article-title":"CCR5Delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study","volume":"13","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb0600","first-page":"68","article-title":"Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain","volume":"28","author":"Palomino-Morales","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0605","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/ard.2007.079111","article-title":"Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis","volume":"67","author":"Radstake","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0610","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.01147.x","article-title":"Chemokine receptor CCR5: from AIDS to atherosclerosis","volume":"162","author":"Jones","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0615","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2016.07.026_bb0620","doi-asserted-by":"crossref","first-page":"30603","DOI":"10.1074\/jbc.272.49.30603","article-title":"Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32","volume":"272","author":"Benkirane","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.07.026_bb0625","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1089\/088922200750054747","article-title":"Intranasal immunization with HIV reverse transcriptase: effect of dose in the induction of helper T cell type 1 and 2 immunity","volume":"16","author":"Pacheco","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.autrev.2016.07.026_bb0630","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.thromres.2005.12.016","article-title":"Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease","volume":"119","author":"Apostolakis","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2016.07.026_bb0635","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2007.10.007","article-title":"Genetic control of chemokines in severe human internal carotid artery stenosis","volume":"41","author":"Ghilardi","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2016.07.026_bb0640","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.gene.6363760","article-title":"Genetic variation at the chemokine receptors CCR5\/CCR2 in myocardial infarction","volume":"2","author":"Gonz\u00e1lez","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2016.07.026_bb0645","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2796.2005.01491.x","article-title":"CC chemokine receptor 5 (CCR5) deletion polymorphism does not protect Czech males against early myocardial infarction","volume":"257","author":"Petrkova","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0650","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0021-9150(01)00423-3","article-title":"Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G\/G genotype in CAD patients","volume":"158","author":"Szalai","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0655","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/1529-0131(199905)42:5<989::AID-ANR18>3.0.CO;2-U","article-title":"Association of rheumatoid arthritis with a functional chemokine receptor, CCR5","volume":"42","author":"G\u00f3mez-Reino","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0660","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/03009740701393999","article-title":"The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients","volume":"36","author":"Kohem","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0665","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.gene.6364298","article-title":"Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis","volume":"7","author":"Prahalad","year":"2006","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2016.07.026_bb0670","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.107.729125","article-title":"Macrophage migration inhibitory factor in cardiovascular disease","volume":"117","author":"Zernecke","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb0675","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0680","doi-asserted-by":"crossref","first-page":"860651","DOI":"10.1155\/2014\/860651","article-title":"Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis","volume":"2014","author":"Genre","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2016.07.026_bb0685","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cytogfr.2007.04.007","article-title":"The emerging role of adipokines as mediators of inflammation and immune responses","volume":"18","author":"Lago","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb0690","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrrheum.2011.107","article-title":"What's new in our understanding of the role of adipokines in rheumatic diseases?","volume":"7","author":"G\u00f3mez","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0695","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tcm.2007.09.005","article-title":"The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives","volume":"17","author":"Gualillo","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0700","doi-asserted-by":"crossref","first-page":"125458","DOI":"10.1155\/2012\/125458","article-title":"Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases","volume":"2012","author":"Scotece","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2016.07.026_bb0705","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1463-1326.2006.00610.x","article-title":"Adiponectin in health and disease","volume":"9","author":"Oh","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.autrev.2016.07.026_bb0710","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1749-6632.2010.05875.x","article-title":"Scherer. Adipokines as novel biomarkers and regulators of the metabolic syndrome","volume":"1212","author":"Deng","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2016.07.026_bb0715","first-page":"596","article-title":"High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis","volume":"26","author":"Gonzalez-Gay","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0720","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1753944710371483","article-title":"Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population","volume":"4","author":"Chiodini","year":"2010","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0725","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1469-1809.2006.00340.x","article-title":"Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects","volume":"71","author":"Gable","year":"2007","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0730","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1160\/TH06-11-0646","article-title":"The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men","volume":"97","author":"Hoefle","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2016.07.026_bb0735","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s11033-010-0320-y","article-title":"Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population","volume":"38","author":"Liu","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2016.07.026_bb0740","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/db06-0506","article-title":"Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease","volume":"56","author":"Menzaghi","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2016.07.026_bb0745","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/eurheartj\/ehm526","article-title":"Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects","volume":"29","author":"Patel","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2016.07.026_bb0750","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1399-0039.2010.01580.x","article-title":"Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients","volume":"77","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2016.07.026_bb0755","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0760","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.93.25.14564","article-title":"Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells","volume":"93","author":"Gainsford","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.07.026_bb0765","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2016.07.026_bb0770","first-page":"222","article-title":"Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis","volume":"27","author":"Gonzalez-Gay","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0775","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.ijo.0800567","article-title":"A polymorphism in the 5' untranslated region of the human ob gene is associated with low leptin levels","volume":"22","author":"Hager","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.autrev.2016.07.026_bb0780","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1469-1809.1999.6330227.x","article-title":"Sequence variants in the 5' flanking region of the leptin gene are associated with obesity in women","volume":"63","author":"Li","year":"1999","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0785","first-page":"293","article-title":"Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis","volume":"29","author":"Garc\u00eda-Berm\u00fadez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0790","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/art.30291","article-title":"Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?","volume":"63","author":"Neumann","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0795","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2016.07.026_bb0800","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1074\/jbc.M201451200","article-title":"Mechanisms regulating adipocyte expression of resistin","volume":"277","author":"Hartman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.07.026_bb0805","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2003.07.003","article-title":"Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro","volume":"309","author":"Kaser","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2016.07.026_bb0810","first-page":"311","article-title":"Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis","volume":"26","author":"Gonzalez-Gay","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0815","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1464-5491.2005.01480.x","article-title":"Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients","volume":"22","author":"Kunnari","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0820","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabres.2008.10.021","article-title":"Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients","volume":"84","author":"Tsukahara","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.autrev.2016.07.026_bb0825","first-page":"19","article-title":"Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients","volume":"29","author":"Rodriguez-Rodriguez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0830","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.autrev.2016.07.026_bb0835","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/diabetes.54.10.2911","article-title":"Plasma visfatin concentrations and fat depot-specific mRNA expression in humans","volume":"54","author":"Berndt","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2016.07.026_bb0840","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0845","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.22833","article-title":"Pre-B cell colony-enhancing factor\/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities","volume":"56","author":"Brentano","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0850","first-page":"681","article-title":"Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis","volume":"29","author":"Garc\u00eda-Berm\u00fadez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0855","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.2337\/db06-0189","article-title":"Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population","volume":"55","author":"Bailey","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2016.07.026_bb0860","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.metabol.2008.06.011","article-title":"The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects","volume":"57","author":"Johansson","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.autrev.2016.07.026_bb0865","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000314770","article-title":"Innate immunity in atherosclerosis","volume":"2","author":"Bj\u00f6rkbacka","year":"2010","journal-title":"J Innate Immun"},{"key":"10.1016\/j.autrev.2016.07.026_bb0870","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.med.54.101601.152421","article-title":"Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism","volume":"54","author":"Costa","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0875","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0880","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2016.07.026_bb0885","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2016.07.026_bb0890","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bcp.2004.08.027","article-title":"Modulation of paraoxonase (PON1) activity","volume":"69","author":"Costa","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0895","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.38118","article-title":"Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis","volume":"65","author":"Charles-Schoeman","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb0900","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1136\/annrheumdis-2014-205543","article-title":"Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"73","author":"L\u00f3pez-Mej\u00edas","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0905","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/art.39609","article-title":"Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease","volume":"68","author":"Rodr\u00edguez-Carrio","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0910","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1124\/pr.58.4.6","article-title":"International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor","volume":"58","author":"Moore","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb0915","doi-asserted-by":"crossref","first-page":"470805","DOI":"10.1155\/2015\/470805","article-title":"Vitamin D and inflammatory bowel disease","volume":"2015","author":"Ardesia","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2016.07.026_bb0920","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.diabet.2012.11.004","article-title":"Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: the DIABHYCAR prospective study","volume":"39","author":"Ferrarezi","year":"2013","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.autrev.2016.07.026_bb0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102141","article-title":"Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity","volume":"9","author":"Al-Daghri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb0930","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2015.12.011","article-title":"Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis","volume":"245","author":"L\u00f3pez-Mej\u00edas","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb0935","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.0000143233.87854.23","article-title":"Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability","volume":"110","author":"Moreno","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb0940","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/07853890802186913","article-title":"Inflammatory angiogenesis in atherogenesis-a double-edged sword","volume":"40","author":"Ribatti","year":"2008","journal-title":"Ann Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0945","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/01.CIR.0000132468.82942.F5","article-title":"Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis","volume":"109","author":"Epstein","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb0950","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0955","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/86490","article-title":"Vascular endothelial growth factor enhances atherosclerotic plaque progression","volume":"7","author":"Celletti","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb0960","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2016.07.026_bb0965","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0008-6363(98)00255-7","article-title":"Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?","volume":"41","author":"de Boer","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2016.07.026_bb0970","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.07.026_bb0975","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M009705200","article-title":"Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells","volume":"276","author":"Kim","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.07.026_bb0980","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diabetes.48.5.1131","article-title":"Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells","volume":"48","author":"Marumo","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2016.07.026_bb0985","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/hc0902.104718","article-title":"Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting\/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis","volume":"105","author":"Zhao","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb0990","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng1211","article-title":"VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death","volume":"34","author":"Lambrechts","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb0995","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0039.2010.01625.x","article-title":"Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients","volume":"77","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2016.07.026_bb1000","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157016112798829760","article-title":"The role of nitric oxide on endothelial function","volume":"10","author":"Tousoulis","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/heart.85.3.342","article-title":"Endothelial function and nitric oxide: clinical relevance","volume":"85","author":"Vallance","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.autrev.2016.07.026_bb1015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF03401758","article-title":"Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review","volume":"4","author":"Weinberg","year":"1998","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb1020","first-page":"2178","article-title":"Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1025","first-page":"1081","article-title":"Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch\u2013Schonlein purpura in northwestern Spain","volume":"32","author":"Martin","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1030","first-page":"S79","article-title":"Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with Behcet's disease","volume":"24","author":"Oksel","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1035","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/rheumatology\/keh283","article-title":"Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain","volume":"43","author":"Gonzalez-Gay","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.07.026_bb1040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.gene.6363856","article-title":"Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism","volume":"3","author":"Pascual","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2016.07.026_bb1045","first-page":"116","article-title":"Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis","volume":"27","author":"Gonzalez-Gay","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1050","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb1055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clim.2009.07.016","article-title":"Innate immune signals in atherosclerosis","volume":"134","author":"Lundberg","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1065","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nm1008","article-title":"Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways","volume":"10","author":"Bj\u00f6rkbacka","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb1070","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.07.026_bb1075","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1161\/01.ATV.0000229218.97976.43","article-title":"Scavenger receptors in atherosclerosis: beyond lipid uptake","volume":"26","author":"Moore","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1080","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI25482","article-title":"Modulation of atherosclerosis in mice by Toll-like receptor 2","volume":"115","author":"Mullick","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.07.026_bb1085","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1194\/jlr.R800056-JLR200","article-title":"Emerging role of Toll-like receptors in atherosclerosis","volume":"50","author":"Curtiss","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2016.07.026_bb1090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2779","article-title":"Phagocyte partnership during the onset and resolution of inflammation","volume":"10","author":"Soehnlein","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1097-2765(03)00384-8","article-title":"Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism","volume":"12","author":"Castrillo","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.autrev.2016.07.026_bb1100","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1105","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1110","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1161\/01.ATV.0000101191.92392.1D","article-title":"Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events","volume":"23","author":"Ameziane","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1115","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1161\/01.CIR.0000068311.40161.28","article-title":"Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events","volume":"107","author":"Boekholdt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm1246","article-title":"TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells","volume":"11","author":"Krutzik","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb1125","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1089\/dna.2011.1582","article-title":"Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"31","author":"Garc\u00eda-Berm\u00fadez","year":"2012","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1130","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2016.07.026_bb1135","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.4049\/jimmunol.179.7.4867","article-title":"Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity","volume":"179","author":"Fontalba","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.2008.106989","article-title":"CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis","volume":"69","author":"Kastbom","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/dna.2012.1836","article-title":"CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients","volume":"32","author":"Garc\u00eda-Berm\u00fadez","year":"2013","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1150","first-page":"20","article-title":"Molecular biology of 5,10-methylenetetrahydrofolate reductase","volume":"13","author":"F\u00f6dinger","year":"2000","journal-title":"J Nephrol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","article-title":"A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity","volume":"64","author":"Weisberg","year":"1998","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.autrev.2016.07.026_bb1165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","article-title":"Role of homocysteine in the development of cardiovascular disease","volume":"14","author":"Ganguly","year":"2015","journal-title":"Nutr J"},{"key":"10.1016\/j.autrev.2016.07.026_bb1170","first-page":"163","article-title":"The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients","volume":"26","author":"Rubini","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1175","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar2989","article-title":"A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis","volume":"12","author":"Palomino-Morales","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1180","first-page":"106","article-title":"Decreased expression of methylene tetrahydrofolate reductase (MTHFR) gene in patients with rheumatoid arthritis","volume":"34","author":"Remuzgo-Mart\u00ednez","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/BJ20070929","article-title":"Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals","volume":"407","author":"Kim","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2016.07.026_bb1190","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.jid.5701100","article-title":"Methionine sulfoxide reductases A and B are deactivated by hydrogen peroxide (H2O2) in the epidermis of patients with vitiligo","volume":"128","author":"Schallreuter","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1195","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/03009742.2012.677063","article-title":"Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis","volume":"41","author":"Garc\u00eda-Berm\u00fadez","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2011.04.019","article-title":"The effects of ghrelin on inflammation and the immune system","volume":"340","author":"Baatar","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1205","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tsch\u00f6p","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2016.07.026_bb1210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI200421134","article-title":"Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells","volume":"114","author":"Dixit","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.07.026_bb1215","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.0000127956.43874.F2","article-title":"Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells","volume":"109","author":"Li","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1220","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/hmg\/ddm033","article-title":"Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease","volume":"16","author":"Baessler","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1225","first-page":"142","article-title":"Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"29","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1230","first-page":"95","article-title":"Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms","volume":"50","author":"Bottini","year":"2002","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.autrev.2016.07.026_bb1235","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/BF00502609","article-title":"Immunochemical characterization of human red cell acid phosphatase isozyMetS","volume":"25","author":"Dissing","year":"1987","journal-title":"Biochem Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1240","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00018-008-8501-8","article-title":"From immune response to cancer: a spot on the low molecular weight protein tyrosine phosphatase","volume":"66","author":"Souza","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2016.07.026_bb1245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/bbrc.1996.0174","article-title":"Low M(r) phosphotyrosine protein phosphatase interacts with the PDGF receptor directly via its catalytic site","volume":"219","author":"Chiarugi","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2016.07.026_bb1250","doi-asserted-by":"crossref","first-page":"24220","DOI":"10.1074\/jbc.M202885200","article-title":"Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP)","volume":"277","author":"Bottini","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.07.026_bb1255","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF00210290","article-title":"ACP1 and human adaptability. 1. Association with common diseases: a case\u2013control study","volume":"96","author":"Bottini","year":"1995","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1260","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000203405","article-title":"ACP1 genetic polymorphism and coronary artery disease: an association study","volume":"113","author":"Banci","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.autrev.2016.07.026_bb1265","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar3401","article-title":"Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients","volume":"13","author":"Teruel","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1270","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1275","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/rheumatology\/kel005","article-title":"The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis","volume":"45","author":"Hinks","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.07.026_bb1280","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/art.20771","article-title":"Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus","volume":"52","author":"Orozco","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb1285","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":"TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study","volume":"357","author":"Plenge","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb1290","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/hmg\/ddn128","article-title":"Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility","volume":"17","author":"Barton","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1295","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.23549","article-title":"Association of STAT4 with rheumatoid arthritis: a replication study in three European populations","volume":"58","author":"Orozco","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb1300","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.07.026_bb1305","first-page":"695","article-title":"Lack of association of PTPN22, STAT4 and TRAF1\/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis","volume":"28","author":"Palomino-Morales","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1310","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar2947","article-title":"TRAF1\/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies","volume":"12","author":"van Nies","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1315","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ng.920","article-title":"Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque","volume":"43","author":"Bis","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1320","doi-asserted-by":"crossref","first-page":"756279","DOI":"10.1155\/2014\/756279","article-title":"Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima\u2013media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis","volume":"2014","author":"L\u00f3pez-Mej\u00edas","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2016.07.026_bb1325","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1330","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1136\/annrheumdis-2015-207851","article-title":"Association of chemokine CXC ligand 12 gene polymorphism (rs1746048) with cardiovascular mortality in patients with rheumatoid arthritis: results from the Norfolk Arthritis Register","volume":"74","author":"Ibrahim","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1335","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/ar4335","article-title":"The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima\u2013media thickness in patients with rheumatoid arthritis","volume":"15","author":"L\u00f3pez-Mej\u00edas","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1340","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/ar3755","article-title":"The lp13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis","volume":"14","author":"L\u00f3pez-Mej\u00edas","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1345","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1089\/dna.2012.1672","article-title":"Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients","volume":"31","author":"Garc\u00eda-Berm\u00fadez","year":"2012","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1350","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.humimm.2012.02.012","article-title":"Lack of association between the CXCL12 rs501120 polymorphism and cardiovascular disease in Spanish patients with rheumatoid arthritis","volume":"73","author":"L\u00f3pez-Mej\u00edas","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1355","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tan.12217","article-title":"The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis","volume":"82","author":"L\u00f3pez-Mej\u00edas","year":"2013","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2016.07.026_bb1360","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1093\/hmg\/ddn246","article-title":"Autoimmune diseases: insights from genome-wide association studies","volume":"17","author":"Lettre","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1365","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nri2361","article-title":"Genome-wide association studies: a new window into immune-mediated diseases","volume":"8","author":"Xavier","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar3204","article-title":"Promise and pitfalls of the Immunochip","volume":"13","author":"Cortes","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1375","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrg2344","article-title":"Genome-wide association studies for complex traits: consensus, uncertainty and challenges","volume":"9","author":"McCarthy","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1380","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrg2316","article-title":"The road to genome-wide association studies","volume":"9","author":"Kruglyak","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1385","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2016.07.026_bb1390","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ng.2007.27","article-title":"Two independent alleles at 6q23 associated with risk of rheumatoid arthritis","volume":"39","author":"Plenge","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1395","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.0000138740.84883.9C","article-title":"Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis","volume":"110","author":"Reilly","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1400","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/01.CIR.0000088846.10655.E0","article-title":"The metabolic syndrome: more than the sum of its parts?","volume":"108","author":"Reilly","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1405","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1410","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.autrev.2009.01.001","article-title":"Metabolic syndrome in rheumatological diseases","volume":"8","author":"Pereira","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb1415","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar2397","article-title":"Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications","volume":"10","author":"Sidiropoulos","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1420","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.atherosclerosis.2007.01.004","article-title":"Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis","volume":"196","author":"Chung","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1425","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.autrev.2011.04.018","article-title":"The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk","volume":"10","author":"Gremese","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb1430","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2005.040857","article-title":"No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis","volume":"65","author":"H\u00e4rle","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1435","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrrheum.2012.158","article-title":"Rheumatoid arthritis: obesity impairs efficacy of anti-TNF therapy in patients with RA","volume":"8","author":"Gonz\u00e1lez-Gay","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1440","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","article-title":"Interleukin-6 induces cellular insulin resistance in hepatocytes","volume":"51","author":"Senn","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2016.07.026_bb1445","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.2337\/diabetes.54.suppl_2.S114","article-title":"Interleukin-6 and diabetes: the good, the bad, or the indifferent?","volume":"54","author":"Kristiansen","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2016.07.026_bb1450","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2010.12.005","article-title":"Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein","volume":"53","author":"Nishida","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2016.07.026_bb1455","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1460","first-page":"161","article-title":"Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis","volume":"24","author":"Dessein","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1465","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/ard.2008.088773","article-title":"Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis","volume":"67","author":"Gonzalez-Gay","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1470","first-page":"358","article-title":"Lack of association between adipokines and ghrelin and carotid intima\u2013media thickness in patients with severe rheumatoid arthritis","volume":"29","author":"Gonzalez-Gay","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1475","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar4308","article-title":"Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study","volume":"15","author":"Dessein","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1480","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/art.27376","article-title":"Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis","volume":"62","author":"Rho","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb1485","doi-asserted-by":"crossref","first-page":"358949","DOI":"10.1155\/2014\/358949","article-title":"Adiponectin and atherosclerosis in rheumatoid arthritis","volume":"2014","author":"Dessein","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2016.07.026_bb1490","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar4384","article-title":"Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis","volume":"15","author":"Kang","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1495","first-page":"698","article-title":"The serum levels of resistin in rheumatoid arthritis patients","volume":"24","author":"Migita","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1500","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/ard.2006.054734","article-title":"Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum","volume":"66","author":"Senolt","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1505","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1136\/annrheumdis-2013-203587","article-title":"Independent relationship between circulating resistin concentrations and endothelial activation in rheumatoid arthritis","volume":"72","author":"Dessein","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1510","first-page":"56","article-title":"Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy","volume":"28","author":"Gonzalez-Gay","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1515","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.tips.2003.10.004","article-title":"Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease","volume":"24","author":"Ulbrich","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2016.07.026_bb1520","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1525","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(01)06104-9","article-title":"Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis","volume":"358","author":"Malik","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.07.026_bb1530","first-page":"373","article-title":"Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1535","first-page":"155","article-title":"Lack of association between carotid intima\u2013media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy","volume":"37","author":"Gonz\u00e1lez-Gay","year":"2012","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.autrev.2016.07.026_bb1540","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/rheumatology\/keq378","article-title":"Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease","volume":"50","author":"Westra","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.07.026_bb1545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ibd.20269","article-title":"Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohn's disease patients","volume":"14","author":"Pousa","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1550","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1517\/13543784.12.6.933","article-title":"Angiopoietins in angiogenesis and beyond","volume":"12","author":"Tsigkos","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.autrev.2016.07.026_bb1555","first-page":"761","article-title":"Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis","volume":"31","author":"L\u00f3pez-Mej\u00edas","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1560","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/rheumatology\/ken495","article-title":"The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis","volume":"48","author":"Corallini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.07.026_bb1565","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.10388","article-title":"High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment","volume":"46","author":"Ziolkowska","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb1570","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/s10165-012-0654-5","article-title":"Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis","volume":"23","author":"Asanuma","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1575","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3899\/jrheum.131037","article-title":"Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis","volume":"41","author":"Dessein","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1580","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3899\/jrheum.140690","article-title":"Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis","volume":"42","author":"L\u00f3pez-Mejias","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1585","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/9732ca63-7532-4b92-8d6e-65c0863f25aa","article-title":"TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL","volume":"8","author":"Di Bartolo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb1590","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.atherosclerosis.2009.11.005","article-title":"An imbalanced OPG\/TRAIL ratio is associated to severe acute myocardial infarction","volume":"210","author":"Secchiero","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1595","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1158\/1078-0432.CCR-12-3027","article-title":"C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway","volume":"19","author":"Secchiero","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.autrev.2016.07.026_bb1600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058225","article-title":"Association of soluble Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) with central adiposity and low-density lipoprotein cholesterol","volume":"8","author":"Brombo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb1605","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/eurheartj\/ehp004","article-title":"Prognostic value of apoptosis markers in advanced heart failure patients","volume":"30","author":"Niessner","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2016.07.026_bb1610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053860","article-title":"Prognostic value of TNF-related apoptosis inducing ligand (TRAIL) in acute coronary syndrome patients","volume":"8","author":"Osmancik","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb1615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004442","article-title":"Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction","volume":"4","author":"Secchiero","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb1620","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2013.04.011","article-title":"The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritis","volume":"63","author":"Audo","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2016.07.026_bb1625","first-page":"491","article-title":"TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis","volume":"33","author":"Dessein","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1630","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00726-015-1953-x","article-title":"Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores","volume":"47","author":"Dimitroulas","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.autrev.2016.07.026_bb1635","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease","volume":"6","author":"Sibal","year":"2010","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.autrev.2016.07.026_bb1640","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0008-6363(03)00500-5","article-title":"The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor","volume":"59","author":"B\u00f6ger","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2016.07.026_bb1645","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","article-title":"Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension","volume":"33","author":"Surdacki","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1650","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0735-1097(01)01318-3","article-title":"Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine","volume":"38","author":"Lundman","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1655","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"B\u00f6ger","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1660","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","article-title":"Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus","volume":"88","author":"Abbasi","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1665","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"St\u00fchlinger","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2016.07.026_bb1670","doi-asserted-by":"crossref","first-page":"347268","DOI":"10.1155\/2012\/347268","article-title":"Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis","volume":"2012","author":"Di Franco","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2016.07.026_bb1675","doi-asserted-by":"crossref","first-page":"270","DOI":"10.20452\/pamw.1277","article-title":"Plasma asymmetric dimethylarginine in active rheumatoid arthritis: links with oxidative stress and inflammation","volume":"122","author":"Kwa\u015bny-Krochin","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.autrev.2016.07.026_bb1680","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/ndt\/gfn670","article-title":"Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes","volume":"24","author":"Schepers","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2016.07.026_bb1685","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00392-012-0515-4","article-title":"Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study","volume":"102","author":"Siegerink","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1690","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.atherosclerosis.2009.06.039","article-title":"Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke","volume":"208","author":"Schulze","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096875","article-title":"Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in pomerania","volume":"9","author":"Schwedhelm","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.026_bb1700","doi-asserted-by":"crossref","first-page":"796562","DOI":"10.1155\/2015\/796562","article-title":"Symmetric dimethylarginine is not associated with cumulative inflammatory load or classical cardiovascular risk factors in rheumatoid arthritis: a 6-year follow-up study","volume":"2015","author":"Dimitroulas","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2016.07.026_bb1705","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.026_bb1710","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10067-010-1634-9","article-title":"The burden of illness of rheumatoid arthritis","volume":"30","author":"Boonen","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200422001-00002","article-title":"Epidemiology and burden of illness of rheumatoid arthritis","volume":"22","author":"Kvien","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.autrev.2016.07.026_bb1720","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/art.509","article-title":"Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb1725","first-page":"2529","article-title":"Mortality in rheumatoid arthritis: have we made an impact in 4 decades?","volume":"26","author":"Gabriel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1730","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780370808","article-title":"Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period","volume":"37","author":"Jacobsson","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb1735","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/1529-0131(200001)43:1<14::AID-ANR3>3.0.CO;2-7","article-title":"Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis","volume":"43","author":"Krause","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.026_bb1740","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/030097400750001770","article-title":"Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992","volume":"29","author":"Kvalvik","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1745","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/PL00011191","article-title":"Total mortality is increased in rheumatoid arthritis. A 17-year prospective study","volume":"20","author":"Riise","year":"2001","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1750","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.07.026_bb1755","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.biopha.2006.09.006","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"60","author":"Gonzalez-Gay","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2016.07.026_bb1760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2012.05.007","volume":"223","author":"Perk","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1765","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2016.07.026_bb1770","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.026_bb1775","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","article-title":"Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis","volume":"74","author":"Arts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.026_bb1780","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:40:08Z","timestamp":1749037208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216301719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":356,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1568997216301719"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.026","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}